Janssen Sciences Ireland Uc

Janssen Pharmaceutica Nv

Elanco Animal Health Ireland Limited

Nacer Lounis

Anil Koul

Magali Madeleine Simone Motte

Jérôme Émile Georges Guillemont

Jean-François Bonfanti

Jérôme Michel Claude Fortin

Philippe Muller

Frédéric Marc Maurice Doublet

Pierre Jean-Marie Bernard Raboisson

Jérôme Emile Georges Guillemont

Jerôme Emile Georges Guillemont

Jean-Francois Bonfanti

Jerome Emile Guillemont

Magali Madeleine Motte

Jerome Michel Fortin

Frederic Marc Doublet

The present invention relates to novel compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein the integers are as defined in the description. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.

Pyrimidine derivatives for the treatment of bacterial diseases

The present invention relates to the following compounds for use in the treatment of a bacterial infection wherein the integers are as defined in the description. The invention also relates to compounds for use as medicaments, pharmaceutical compositions and some novel compounds.

Antibacterial compounds

The present invention is related to novel compounds of formula (I) having antibacterial activity againstbacteria, in particular, pharmaceutical compositions comprising these compounds, and chemical processes for preparing these compounds. 

[object Object]

Growing community of inventors

Beerse, Belgium

Nacer Lounis